|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| C07K 14/55 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 37/00 |
| (11) | Patento numeris | 2970486 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14723938.8 |
| Europos patento paraiškos padavimo data | 2014-03-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-05-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/030758 |
| Data | 2014-03-17 |
| (87) | Numeris | WO 2014/145907 |
| Data | 2014-09-18 |
| (30) | Numeris | Data | Šalis |
| 201361800743 P | 2013-03-15 | US | |
| 201361911438 P | 2013-12-03 | US |
| (72) |
CHU, Seung, US
WICKRAMARACHICHI, Dilki, US
BERNETT, Matthew, J., US
DESJARLAIS, John, US
|
| (73) |
Xencor, Inc.,
111 W. Lemon Avenue, Monrovia, CA 91016,
US
|
| (54) | MODULATION OF T CELLS WITH BISPECIFIC ANTIBODIES AND FC FUSIONS |
| MODULATION OF T CELLS WITH BISPECIFIC ANTIBODIES AND FC FUSIONS |